PMC:7283670 / 17590-17738 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T101","span":{"begin":116,"end":124},"obj":"Disease"}],"attributes":[{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T57801","span":{"begin":82,"end":86},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T95937","span":{"begin":82,"end":86},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T40101","span":{"begin":140,"end":141},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T44","span":{"begin":15,"end":20},"obj":"Chemical"},{"id":"T45","span":{"begin":82,"end":86},"obj":"Chemical"}],"attributes":[{"id":"A44","pred":"chebi_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"}],"text":" critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total "}

{"project":"LitCovid-sentences","denotations":[{"id":"T137","span":{"begin":22,"end":139},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total "}

{"project":"LitCovid-PubTator","denotations":[{"id":"402","span":{"begin":59,"end":64},"obj":"Species"},{"id":"403","span":{"begin":87,"end":95},"obj":"Species"},{"id":"410","span":{"begin":35,"end":44},"obj":"Disease"},{"id":"411","span":{"begin":116,"end":124},"obj":"Disease"}],"attributes":[{"id":"A402","pred":"tao:has_database_id","subj":"402","obj":"Tax:9606"},{"id":"A403","pred":"tao:has_database_id","subj":"403","obj":"Tax:9606"},{"id":"A410","pred":"tao:has_database_id","subj":"410","obj":"MESH:D003643"},{"id":"A411","pred":"tao:has_database_id","subj":"411","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total "}